Neurology Letters
Oral Presentations: Abstracts of the 20th Iranian Multiple Sclerosis Congress
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Poster Presentations: Abstracts of the 20th Iranian Multiple Sclerosis Congress
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mind and Art (ORP-01)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Zahra Niknam
MS Prodrome; Is it a fact? (ORP-02)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Farhad Golipoor
A narrative review on the dietary interventions in multiple sclerosis (ORP-03)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Nasim Rezaeimanesh
The importance of vestibular evaluation and rehabilitation in improving the balance in MS patients (ORP-04)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Saeideh Mehrkian
Physical disability assessment: EDSS calculation (ORP-05)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Zahra Ebadi
Horizons of MS therapy: during 30 years (ORP-06)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Seyed Massood Nabavi
Women and Multiple Sclerosis (ORP-07)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Behnaz Sedighi
Clinical Outcome and Volumetric MRI Assessment of Brain and Cervical Spinal Cord Area in Secondary Progressive Multiple Sclerosis Patients Treated with Rituximab: one-year follow-up (ORP-08)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Yousef Mokary; Mohammad Yazdan Panah; Fereshteh Ashtari; Maryam Ahmadi
The role of Artificial Intelligence in cognitive impairment assessment by MRI in people with MS (Iranian Research) (ORP-09)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Vida Niakosari; Sana Hashemi; Ahmad Ali Abin; Maryam Poursadeghfard
Definition and treatment of the multiple sclerosis relapse (ORP-10)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Maryam Poursadeghfard
Patients Monitoring During Treatment With Injectable DMDs (INF and GA) (ORP-11)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Zahra Nikoo
Everything we need to know about vaccination in MS (ORP-12)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Hossein Mozhdehipanah
Typical MRI lesions of multiple sclerosis in the brain and spinal cord (ORP-13)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Zahra Hamed
Advanced imaging for multiple sclerosis (ORP-14)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Elnaz Asadollahzadeh
Diagnostic approach to autoimmune encephalitis (ORP-15)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Hoda Kamali
Femoral head AVN concept and treatments (ORP-16)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Seyyed Hossein Shafiei; Mohammad Soleimani; Alireza Nankali
Brain Stimulation for Cognitive impairment in Multiple Sclerosis (ORP-17)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mehrdad Roozbeh
MS and cognition: review of clinical, neuro-radiological features, and treatment (ORP-18)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Mahnaz Talebi
Comorbidity in patients with MS (ORP-19)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Fereshteh Ashtari
Review of McDonald criteria (ORP-20)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Atefeh Eidi
Defining seizure type and frequency, and analyzing MRI and EEG findings in MS populations of Khorasan. A cross-sectional study (ORP-21)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Karim Nikkhah; Mahshid Mahyad; H. Abbasi
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria (ORP-22)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Samaneh Hosseini
Patients monitoring during treatment with Dimethyl fumarate (ORP-23)
Volume 2, Supplementary 1 (20th Iranian Multiple Sclerosis Congress), December 2023
Ali Yousefi Pour
)